Sucampo Pharmaceuticals
Manufacturing · Ireland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
College Business & Technology Park Cruis...Phone Number
(301) 961-3400Website
www.sucampo.comRevenue
$247.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Sucampo Pharmaceuticals
Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing, identifying, acquiring, and marketing medicines that meet unmet medical needs, primarily in gastroenterology, ophthalmology, and oncology-related disorders in the United States, Japan, Switzerland, and internationally. The companys marketed product includes AMITIZA (lubiprostone), a ClC-2 chloride channel activator for the treatment of chronic idiopathic constipation (CIC) in adults, irritable bowel syndrome with constipation in adult women (IBS-C), and opioid-induced constipation (OIC)in patients with chronic non-cancer related pain; and RESCULA (unoprostone isopropyl), a big potassium channel activator for the treatment of glaucoma and ocular hypertension. Its product candidates in clinical development stage comprise Lubiprostone that is in Phase III clinical trials for the treatment of pediatric functional constipation and (IBS-C); and completed Phase III clinical trials for the treatment of (CIC) inRead more
Sucampo Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sucampo Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Sucampo Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Sucampo Pharmaceuticals
Website visits: Recent activity has been detected on your website
Check if Sucampo Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Sucampo Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Sucampo Pharmaceuticals recently announced quarterly report
Click to see if Sucampo Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Sucampo Pharmaceuticals has new funding data
Product Launch: Get notified when Sucampo Pharmaceuticals launches new products
Recommended Actions
Reach out to Masked Content who joined Sucampo Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Sucampo Pharmaceuticals
Compare insights from companies similar to Sucampo Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sucampo Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sucampo Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sucampo Pharmaceuticals.
Sucampo Pharmaceuticals financials insights
Gather financial insights about Sucampo Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Stock Offering
$43.1M
2015
Debt
$250M
Sucampo Pharmaceuticals Tech Stack
A closer look at the technologies used by Sucampo Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sucampo Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing, identifying, acquiring, and marketing medicines that meet unmet medical needs, primarily in gastroenterology, ophthalmology, and oncology-related disorders in the United States, Japan, Switzerland, and internationally. The companys marketed product includes AMITIZA (... Read More
